Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure

NCT03296813 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03296813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03296813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure
Lead sponsor
Duke University
Phase
Phase 3
Overall status
Completed
Start date
July 11, 2018
Completion date
July 29, 2022
Enrollment
2,973 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure